SCHEMBL23221306

SCHEMBL23221306

CN(C)c1cc(-c2cccc(C(N)=O)c2)ncn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.55
MAPK1 P28482 2/20 0.55
ALDH1A1 P00352 2/20 0.55
CYP3A4 P08684 2/20 0.55
HSD17B10 Q99714 2/20 0.55
TP53 P04637 1/20 0.55
ALOX15 P16050 1/20 0.55
TSHR P16473 1/20 0.55
FYN P06241 2/20 0.48
KDM4E B2RXH2 1/20 0.46
ABL1 P00519 1/20 0.46
MAPT P10636 1/20 0.46
BCR P11274 1/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 1/20 0.46
KDM1A O60341 1/20 0.43
LIMK1 P53667 2/20 0.43
KMO O15229 2/20 0.43
PARP1 P09874 1/20 0.42
PIK3CA P42336 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27597126 0.81 CYP1A2 (0.54) CYP1A2MAPK1ALDH1A1CYP3A4HSD17B10
SCHEMBL23809638 0.79 ASIC3 (0.59) MAPK1KDM4EABL1MAPTBCR
SCHEMBL1445810 0.78 MIF (0.57) MAPK1FYNKDM4EABL1MAPT
SCHEMBL23221307 0.77 ABL1 (0.58) CYP1A2MAPK1HSD17B10TP53ALOX15
SCHEMBL3664142 0.77 FYN (0.57) MAPK1FYNABL1KDM1ALIMK1
SCHEMBL5562447 0.76 CYP1A2 (0.48) CYP1A2MAPK1ALDH1A1CYP3A4HSD17B10
SCHEMBL4108901 0.75 ABL1 (0.58) CYP1A2MAPK1ALDH1A1CYP3A4HSD17B10
SCHEMBL23221380 0.74 CYP1A2 (0.62) CYP1A2MAPK1ALDH1A1CYP3A4HSD17B10
SCHEMBL842300 0.73 PARP1 (0.61) FYNABL1BCRKDM1AKMO
SCHEMBL1445168 0.73 FYN (0.52) MAPK1FYNKDM4EABL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3523291-B1 CYANO-SUBSTITUTED HETEROCYCLES WITH ACTIVITY AS INHIBITORS OF USP30 MISSION THERAPEUTICS LTD (GB) 2021-04-14 EP disclosed